The mountain is calling

The development of alpine tourism and the increasing trend towards adventure travel have made high mountain regions accessible not only to healthy people, but also to patients with cardiorespiratory diseases such as COPD. However, they are also more susceptible to altitude-related illnesses. Swiss doctors investigated whether prophylactic treatment with acetazolamide (AZA) changes the physical performance of COPD patients at high altitudes.